Avalo Therapeutics, Inc. · NASDAQ:AVTX
Point72 Asset Management, L.P. reported a 8.00% stake in Avalo Therapeutics, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Point72 Asset Management, L.P. reported a 8.00% stake in Avalo Therapeutics, Inc., 1,053,983 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 8.00%
- Shares
- 1,053,983
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 8.00% | 1,053,983 |
| Point72 Capital Advisors, Inc. | 8.00% | 1,053,983 |
| Steven A. Cohen | 8.00% | 1,053,983 |
Source
Related
- Avalo Therapeutics, Inc.
- Point72 Asset Management, L.P.
- Avalo Therapeutics, Inc. shareholders
- Schedule 13G · Point72 Asset Management, L.P. · May 26, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Feb 17, 2026
- Schedule 13G · Point72 Asset Management, L.P. · Aug 5, 2025
- Form 4 · Sullivan Christopher Ryan · Sep 18, 2026
- Form 4 · Sullivan Christopher Ryan · Sep 11, 2026
- Form 4 · Doyle Mittie · Sep 1, 2026
- Form 4 · Sullivan Christopher Ryan · Aug 19, 2026
- Form 4 · Doyle Mittie · Aug 19, 2026